Overview
Genetic urogenital tract malformation is a broad category of rare congenital anomalies affecting the urinary and genital systems that arise due to underlying genetic causes. These malformations encompass a wide spectrum of structural abnormalities involving the kidneys, ureters, bladder, urethra, and genital organs, which develop during embryonic life due to disruptions in the normal developmental pathways of the urogenital system. The severity can range from mild anomalies that may be incidentally discovered to severe malformations that significantly impair renal function or reproductive capacity. Clinical features vary widely depending on the specific structures involved and may include renal agenesis or dysplasia, hydronephrosis, vesicoureteral reflux, hypospadias, cryptorchidism, uterine malformations, or ambiguous genitalia. Many of these conditions are detected prenatally through ultrasound or become apparent in the neonatal period. Some cases are isolated findings, while others occur as part of broader genetic syndromes involving multiple organ systems. The genetic basis is heterogeneous, involving numerous genes critical to urogenital development, and may follow various inheritance patterns depending on the specific underlying genetic defect. Treatment is individualized based on the specific malformation and may include surgical correction, management of renal function, hormonal therapy, or supportive care. Long-term follow-up with nephrology, urology, and genetics specialists is often recommended to monitor for complications such as chronic kidney disease or reproductive difficulties.
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
9 eventsBeaumont Hospital — NA
Georgetown University — NA
Elidah, Inc. — NA
Georgetown University — NA
Children's Hospital of Fudan University
M.D. Anderson Cancer Center — NA
Institut Cancerologie de l'Ouest — NA
University of Kansas Medical Center
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Genetic urogenital tract malformation.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Genetic urogenital tract malformation at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Genetic urogenital tract malformation.
Community
No community posts yet. Be the first to share your experience with Genetic urogenital tract malformation.
Start the conversation →Latest news about Genetic urogenital tract malformation
Disease timeline:
New recruiting trial: Study on Early Genetic Screening and Precise Strategy of Neonatal Critical Illness
A new clinical trial is recruiting patients for Genetic urogenital tract malformation
New recruiting trial: Diagnosis and Management of Intrauterine Growth Restriction and Congenital Anomalies
A new clinical trial is recruiting patients for Genetic urogenital tract malformation
New recruiting trial: Von Willebrand Factor in Pregnancy (VIP) Study
A new clinical trial is recruiting patients for Genetic urogenital tract malformation
New recruiting trial: The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
A new clinical trial is recruiting patients for Genetic urogenital tract malformation
New recruiting trial: Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
A new clinical trial is recruiting patients for Genetic urogenital tract malformation
New recruiting trial: CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
A new clinical trial is recruiting patients for Genetic urogenital tract malformation
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Genetic urogenital tract malformation
What is Genetic urogenital tract malformation?
Genetic urogenital tract malformation is a broad category of rare congenital anomalies affecting the urinary and genital systems that arise due to underlying genetic causes. These malformations encompass a wide spectrum of structural abnormalities involving the kidneys, ureters, bladder, urethra, and genital organs, which develop during embryonic life due to disruptions in the normal developmental pathways of the urogenital system. The severity can range from mild anomalies that may be incidentally discovered to severe malformations that significantly impair renal function or reproductive capa
At what age does Genetic urogenital tract malformation typically begin?
Typical onset of Genetic urogenital tract malformation is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Genetic urogenital tract malformation?
25 specialists and care centers treating Genetic urogenital tract malformation are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.